Fishel Robert Scott 4
4 · OPKO HEALTH, INC. · Filed Jan 26, 2021
Insider Transaction Report
Form 4
Fishel Robert Scott
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-25$2.03/sh+20,000$40,600→ 60,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-25−40,000→ 0 totalExercise: $3.04From: 2019-04-03Exp: 2028-04-02→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2021-01-25$3.04/sh+40,000$121,600→ 40,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-25−20,000→ 0 totalExercise: $2.03From: 2020-06-20Exp: 2029-06-19→ Common Stock (20,000 underlying)
Holdings
- 4,120,728(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.